Family history of prostate cancer should include second- and third-degree relatives
the ONA take:
According to a new study published in the journal The Prostate, researchers from Huntsman Cancer Institute at the University of Utah in Salt Lake City, Utah, have found that looking at a man's second- and third-degree relatives may be as significant as looking at his first-degree relatives to determine his risk for developing prostate cancer.
Typically, a physician will ask a patient about family members with prostate cancer, and that patient may indicate whether it is a first-degree relative, but researchers wanted to know if second- and third-degree relatives were equally as important to estimate prostate cancer risk for men based on prostate cancer family history. The researchers analyzed data from the Utah Population Database to estimate cancer risk for more than 7.3 million people based on family history.
Results showed that 10% of patients had three times the risk and 26% had two times the risk compared with men with no first-, second-, or third-degree relatives with prostate cancer.
The researchers plan to further investigate the effect of having both a maternal and paternal family history of prostate cancer, as well as other factors, to better calculate cancer risk.
The team is also investigating family history risk assessments for breast and lung cancers. Knowing a patient's family history, and therefore risk for developing cancer, will better determine which patients should receive further screening.
A man's second- and third-degree relatives may be as significant as looking at his first-degree relatives to determine his risk for developing prostate cancer.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|